ICE Pharma is proud to announce the inauguration of the new F Block at Raichem, our subsidiary in India — a strategic investment aimed at expanding production capacity and embracing cutting-edge pharmaceutical technology.
A Dedicated Facility for UDCA from Chicken Bile
The F Block has been exclusively designed for the Chicken Bile UDCA Project, enabling a significant scale-up in production. With this new block, ICE Pharma can now increase Raw UDCA output by 120 metric tons per year at the Raichem site, contributing to a total group-wide increase of 100 metric tons annually.
Advanced Technology for Smart, Efficient Manufacturing
The facility is equipped with high-end technology and modern equipment, allowing us to optimize production with minimal manpower. This reflects ICE Pharma’s continued commitment to innovation, efficiency, and sustainable operations in the pharmaceutical manufacturing sector.
Reinforcing Our Commitment to High-Quality APIs
By launching the F Block, ICE Pharma strengthens its position as a leading producer of Ursodeoxycholic Acid (UDCA) and reaffirms its dedication to high standards in API production, responsible sourcing, and technological advancement.
Learn more about our company: ICE Pharma.